Apimeds Pharmaceuticals US, Inc. (APUS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$627.8K2024: -$733.5K2025: -$8.93M-$8.93M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$8.93M-1116.8%
2024-$733.5K-16.8%
2023-$627.8K